$QSEP
QS Energy, Inc.

2023 Q3 Form 10-Q Financial Statement

#000168316823005618 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $47.00K $47.00K
YoY Change -63.85% -4.08%
% of Gross Profit
Depreciation & Amortization $0.00 $1.000K
YoY Change -100.0%
% of Gross Profit
Operating Expenses $47.00K $47.00K
YoY Change -63.85% -4.08%
Operating Profit -$211.0K -$205.0K
YoY Change -38.66% 47.48%
Interest Expense -$90.00K -$79.00K
YoY Change -3.23% 11.27%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$300.0K -$284.0K
YoY Change -31.35% 66.08%
Income Tax
% Of Pretax Income
Net Earnings -$301.0K -$284.0K
YoY Change -31.12% 66.08%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 386.4M shares 385.4M shares
Diluted Shares Outstanding 386.6M shares 385.2M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $210.0K $72.00K
YoY Change -16.67% 35.85%
Cash & Equivalents $214.0K $72.00K
Short-Term Investments
Other Short-Term Assets $30.00K $3.000K
YoY Change 66.67% -83.33%
Inventory
Prepaid Expenses $25.00K $3.000K
Receivables
Other Receivables
Total Short-Term Assets $239.0K $75.00K
YoY Change -11.48% 5.63%
LONG-TERM ASSETS
Property, Plant & Equipment $3.000K $4.000K
YoY Change -57.14% -55.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.000K $4.000K
YoY Change -97.56% -97.04%
TOTAL ASSETS
Total Short-Term Assets $239.0K $75.00K
Total Long-Term Assets $3.000K $4.000K
Total Assets $242.0K $79.00K
YoY Change -38.42% -61.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.139M $2.080M
YoY Change 12.4% 12.8%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.210M $2.017M
YoY Change 17.8% 18.02%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.283M $5.058M
YoY Change 11.5% 9.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.283M $5.058M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $5.283M $5.058M
YoY Change 9.72% 7.16%
SHAREHOLDERS EQUITY
Retained Earnings -$125.1M -$124.8M
YoY Change 1.26% 1.38%
Common Stock $389.0K $385.8K
YoY Change 6.26% 7.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.041M -$4.979M
YoY Change
Total Liabilities & Shareholders Equity $242.0K $79.00K
YoY Change -38.42% -61.65%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$301.0K -$284.0K
YoY Change -31.12% 66.08%
Depreciation, Depletion And Amortization $0.00 $1.000K
YoY Change -100.0%
Cash From Operating Activities -$190.0K -$158.0K
YoY Change -54.0% 95.06%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 330.0K 123.0K
YoY Change -46.08% 68.49%
NET CHANGE
Cash From Operating Activities -190.0K -158.0K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 330.0K 123.0K
Net Change In Cash 140.0K -35.00K
YoY Change -29.65% 288.89%
FREE CASH FLOW
Cash From Operating Activities -$190.0K -$158.0K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$190.0K -$158.0K
YoY Change -54.0% 97.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001103795
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-29185
dei Entity Registrant Name
EntityRegistrantName
QS ENERGY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2088326
dei Entity Address Address Line1
EntityAddressAddressLine1
23902 FM 2978
dei Entity Address City Or Town
EntityAddressCityOrTown
Tomball
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77375
dei City Area Code
CityAreaCode
(775)
dei Local Phone Number
LocalPhoneNumber
300-7647
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
386404006 shares
CY2023Q2 us-gaap Cash
Cash
72000 usd
CY2022Q4 us-gaap Cash
Cash
133000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
19000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
75000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
152000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
98000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
96000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6000 usd
CY2023Q2 us-gaap Assets
Assets
79000 usd
CY2022Q4 us-gaap Assets
Assets
158000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2080000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1962000 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
961000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
946000 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1951000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1865000 usd
CY2023Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
66000 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
75000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5058000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4848000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
5058000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4848000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
385819422 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
385819422 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
376074096 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
376074096 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
385821 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
376075 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119395179 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119075925 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124760000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124142000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4979000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4690000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
158000 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
158000 usd
CY2022Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
90000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
344000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
290000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-205000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-139000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-445000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-387000 usd
CY2023Q2 qsep Gain On Partial Forgiveness Of Ppp Note Payable
GainOnPartialForgivenessOfPppNotePayable
0 usd
CY2022Q2 qsep Gain On Partial Forgiveness Of Ppp Note Payable
GainOnPartialForgivenessOfPppNotePayable
39000 usd
qsep Gain On Partial Forgiveness Of Ppp Note Payable
GainOnPartialForgivenessOfPppNotePayable
0 usd
qsep Gain On Partial Forgiveness Of Ppp Note Payable
GainOnPartialForgivenessOfPppNotePayable
63000 usd
CY2023Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
79000 usd
CY2022Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
71000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
173000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
148000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-284000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-171000 usd
us-gaap Net Income Loss
NetIncomeLoss
-618000 usd
us-gaap Net Income Loss
NetIncomeLoss
-472000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
385223010 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
385223010 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
357665866 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
357665866 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
381838227 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
381838227 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
356709266 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
356709266 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4785000 usd
CY2023Q2 qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
26000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
56000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-284000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4979000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4690000 usd
qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
170000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
103000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
42000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14000 usd
us-gaap Net Income Loss
NetIncomeLoss
-618000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4979000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-4419000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
73000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-171000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-4514000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4173000 usd
qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
6000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
98000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27000 usd
us-gaap Net Income Loss
NetIncomeLoss
-472000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-4514000 usd
us-gaap Net Income Loss
NetIncomeLoss
-618000 usd
us-gaap Net Income Loss
NetIncomeLoss
-472000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
14000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
27000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
65000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
54000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
84000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
71000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000 usd
qsep Gain On Partial Forgiveness Of Ppp Notes Payable
GainOnPartialForgivenessOfPppNotesPayable
-0 usd
qsep Gain On Partial Forgiveness Of Ppp Notes Payable
GainOnPartialForgivenessOfPppNotesPayable
63000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-16000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4000 usd
qsep Decrease In Operating Lease Right Of Use Asset
DecreaseInOperatingLeaseRightOfUseAsset
0 usd
qsep Decrease In Operating Lease Right Of Use Asset
DecreaseInOperatingLeaseRightOfUseAsset
17000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
15000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
109000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
118000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
118000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-16000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-304000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-158000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
42000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
98000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
210000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
qsep Principal Payment On Ppp Loan Payable
PrincipalPaymentOnPppLoanPayable
9000 usd
qsep Principal Payment On Ppp Loan Payable
PrincipalPaymentOnPppLoanPayable
-0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
243000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
98000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-61000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-61000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1600 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
qsep Conversion Of Convertible Debentures To Common Stock
ConversionOfConvertibleDebenturesToCommonStock
170000 usd
qsep Conversion Of Convertible Debentures To Common Stock
ConversionOfConvertibleDebenturesToCommonStock
6000 usd
us-gaap Net Income Loss
NetIncomeLoss
-618000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-304000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4979000 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
1814000 usd
CY2023Q2 us-gaap Cash
Cash
72000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zhplju6oYpu5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_86C_zv7OaQY0dv48">Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accruals for potential liabilities, assumptions used in valuing equity instruments issued for financing and services and realization of deferred tax assets, among others. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
82422788 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
68186971 shares
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49000 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1304000 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1393000 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
696000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
612000 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2000000 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2005000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
49000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
140000 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1951000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1865000 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure

Files In Submission

Name View Source Status
qsep-20230630_pre.xml Edgar Link unprocessable
0001683168-23-005618-index-headers.html Edgar Link pending
0001683168-23-005618-index.html Edgar Link pending
0001683168-23-005618.txt Edgar Link pending
0001683168-23-005618-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qsenergy_ex3101.htm Edgar Link pending
qsenergy_ex3102.htm Edgar Link pending
qsenergy_ex3200.htm Edgar Link pending
qsenergy_i10q-063023.htm Edgar Link pending
qsep-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
qsep-20230630_def.xml Edgar Link unprocessable
qsep-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
qsep-20230630_lab.xml Edgar Link unprocessable
qsenergy_i10q-063023_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending